Ligand Pharmaceuticals, Inc. (LGND)

210.65 +1.13 (+0.54%) USD  |  NASDAQ  |  Mar 19, 16:00
206.01 -4.64 (-2.20%) After-Hours: 06:18
More

Ligand Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
ADMA Biologics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Globus Medical, Inc. Upgrade
Establishment Labs Holdings, Inc. --